Researchers have conducted an analysis of worldwide use of Haemophilus influenza Type b vaccine (Hib) to determine what factors influenced a nation's adoption of the vaccine. The study found that a nation's eligibility for support from the Global Alliance for Vaccine and Immunization and whether a country's neighbors used the vaccine were major influencing factors in addition to price of the vaccine.